Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 39 (RPL21P39)

Target
RPL21P39
Molecular classification
Other (Processed pseudogene), Not classified as receptor, enzyme, transporter, transcription factor, etc.
01

Overview

Ribosomal protein L21 pseudogene 39 (RPL21P39) is a processed pseudogene related to the gene encoding human ribosomal protein L21. Pseudogenes such as RPL21P39 are stretches of DNA that resemble known genes but typically do not encode functional proteins; they arise from duplication or retrotransposition events and often accumulate mutations. There is no established biological function, disease association, or therapeutic relevance for this pseudogene. The functional ribosomal protein L21 (encoded by RPL21), in contrast, is a structural constituent of the ribosome required for protein synthesis[3][5][7]. Mutations in the RPL21 gene—not its pseudogenes—cause disorders like Hypotrichosis simplex. Summary Notes: - RPL21P39 is not a protein-coding gene and should not be confused for an active biomolecular target. - If a therapeutic, biomarker, or molecular target was intended, RPL21 (not RPL21P39) is correct; otherwise, for pseudogenes (like RPL21P39), these fields are null[3][5][7].

Other names
RPL21_14_415RPL21P39

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 39 (RPL21P39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 39 (RPL21P39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call